Back to Gene
GNAI3 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

GNAI3 gene

The GNAI3 gene is responsible for producing an inhibitory protein subunit that regulates cellular signaling and plays a critical role in the development of the head and face.

Normal Function

The GNAI3 gene provides instructions for making the GNAI3 inhibitory alpha subunit, a component of a guanine nucleotide-binding protein (G protein). G proteins consist of alpha, beta, and gamma subunits.

G proteins facilitate signal transduction, transmitting information from the cell's exterior to its interior. The GNAI3 subunit specifically inhibits an enzyme called adenylyl cyclase, which is vital for intracellular communication. By regulating this enzyme, G protein signaling influences cell growth, division, and specialization. Furthermore, this signaling is essential for the development of the first and second pharyngeal arches, which form the bones and tissues of the face, jaw, and ears.

Health Conditions Related to Genetic Changes

Auriculocondylar syndrome

Variants in the GNAI3 gene cause auriculocondylar syndrome, a disorder affecting the development of facial features. Key characteristics include:

  • Abnormalities of the ears
  • Malformation of the lower jaw (mandible)

These genetic variants typically result in the substitution of an amino acid, which alters the structure of the GNAI3 inhibitory alpha subunit. This impairment disrupts G protein signaling and interferes with the proper development of structures derived from the pharyngeal arches.

Frequently Asked Questions

Most individuals with GNAI3 mutations are affected primarily in the craniofacial region. However, some may experience hearing loss or mild developmental delays. Routine developmental screening and audiologic evaluation are recommended to catch any additional issues early.
definitive diagnosis is made through genetic testing, typically a targeted gene panel or whole‑exome sequencing that looks for pathogenic variants in the GNAI3 gene. The test is usually performed on a blood sample and results are interpreted by a clinical geneticist.
Infants with auriculocondylar syndrome often present with ear abnormalities such as microtia, ear malformations, or hearing loss, and may have a noticeably under‑developed lower jaw (mandible) or a cleft palate. These features can be detected during a routine newborn physical exam or early pediatric visit.
While the genetic defect cannot be reversed, early intervention with craniofacial specialists can help. Surgical procedures such as jaw reconstruction, ear reconstruction, or palate repair, combined with orthodontic care and speech therapy, can improve function and appearance. Regular monitoring by a multidisciplinary team is essential.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA